Form 4 for NEOG NEOGEN CORP
Accepted 2021-12-28 00:00:00 ET · period of report 2021-12-23 · accession 0000711377-21-000035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-28 | 2021-12-23 | NEOG | Lilly Jason Warren | VP | S - Sale+OE | $44.91 | -636 | 20.8K | -3% | -$28.6K |
| D | 2021-12-28 | 2021-12-23 | NEOG | Lilly Jason Warren | VP | M - OptEx | $31.35 | +636 | 21.5K | +3% | +$19.9K |
| D | 2021-12-28 | 2021-12-23 | NEOG | Lilly Jason Warren | VP | M - OptEx | $0.00 | -636 | 171.8K | -0.4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-23 | S | D | 636 | $44.91 | 20,838 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-23 | M | A | 636 | $31.35 | 21,474 | D | — | — | |
| 3 | Derivative | Common Stock (Right to Buy) | 2021-12-23 | M | D | 636 | $0.00 | 171,824 | D | $31.35 · — to 2023-12-01 | 636 Common Stock | (F1) Options were granted on 11/1/2018, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant |